A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury
المؤلفون المشاركون
Yusuf, Oyindamola B.
Sadiqi, Muhammad A.
al-Maliki, Abd Allah H.
Ismail, Shirin E.
Qurayshi, Muhammad A.
Balla, Muhammad E.
Karsou, Sulayman
Qurayshi, Rayhan A.
Ahmad, Akram
al-Sulami, Salhah
Khalil, Maryam
Hafiz, Jani
Thomson, Jane E. H.
Zahrani, Ziyad A.
Jasim, Abd al-Hamid
Qadri Mujtaba, K. H.
Abu Najm, Zuhayr
المصدر
Saudi Journal of Kidney Diseases and Transplantation
العدد
المجلد 28، العدد 6 (31 ديسمبر/كانون الأول 2017)، ص ص. 1282-1292، 11ص.
الناشر
تاريخ النشر
2017-12-31
دولة النشر
السعودية
عدد الصفحات
11
التخصصات الرئيسية
الموضوعات
الملخص EN
Clinical pathways have shown conflicting evidence in improvement of several patient-centered outcomes across different clinical settings.
However, the effectiveness of clinical pathway in management of acute kidney injury (AKI) has not been reported.
Therefore, we aimed to assess the length of hospital stay (LOS) and patient-centered outcomes in community acquired AKI and compared pathway care (PC) versus usual care (UC).
The CHAMP-Path AKI Trial is a pragmatic, parallel, single-blind randomized controlled trial.
Physicians were randomized to provide either UC or PC.
Patients were randomized through a computer-generated sequence.
Allocation was concealed.
Patients presenting to the emergency department with AKI and hemodynamic stability, who were over 14 years with a serum creatinine greater than 1.5 times the baseline were eligible.
Patients with chronic kidney disease stages 4 or 5, kidney transplantation recipients, those admitted with obstructive uropathy, suspected glomerular or interstitial disease, and pregnant women were excluded.
Thirty-eight patients were enrolled from March 2012 to December 2013.
The primary outcome was LOS.
Secondary outcomes included: 30-day re- admission, in-hospital respectively (P = 0.770).
Of the five readmissions, none were for AKI.
No in-hospital mortality was reported.
The CHAMP-Path AKI pragmatic trial demonstrated that PC was not different than UC in reducing LOS.
There was no difference in 30-day readmission, in-hospital mortality, and patient-centered outcomes.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
al-Maliki, Abd Allah H.& Ismail, Shirin E.& Qurayshi, Muhammad A.& Abu Najm, Zuhayr& Balla, Muhammad E.& Karsou, Sulayman…[et al.]. 2017. A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury. Saudi Journal of Kidney Diseases and Transplantation،Vol. 28, no. 6, pp.1282-1292.
https://search.emarefa.net/detail/BIM-785632
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
al-Maliki, Abd Allah H.…[et al.]. A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury. Saudi Journal of Kidney Diseases and Transplantation Vol. 28, no. 6 (Nov. / Dec. 2017), pp.1282-1292.
https://search.emarefa.net/detail/BIM-785632
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
al-Maliki, Abd Allah H.& Ismail, Shirin E.& Qurayshi, Muhammad A.& Abu Najm, Zuhayr& Balla, Muhammad E.& Karsou, Sulayman…[et al.]. A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury. Saudi Journal of Kidney Diseases and Transplantation. 2017. Vol. 28, no. 6, pp.1282-1292.
https://search.emarefa.net/detail/BIM-785632
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 1290-1292
رقم السجل
BIM-785632
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر